Accurate. Consistent. Rigorous.
Genelex has been providing genotyping services for clinical trials and research studies since 2000. A recognized leader in DNA testing and analysis, Genelex offers unrivaled depth of experience to pharmaceutical companies and contract research organizations (CROs).
The advantages of working with Genelex include:
- Dedicated customer support
- Rapid 2-day turnaround available
- Customizable assay design and development
- Test validation across multiple platforms
- Ability to test non-invasive buccal samples or blood
- Forensic-level protocols for sample accessioning
- Robotic DNA extraction and testing, to ensure high accuracy and low error
- Capacity to test for more allele mutations than any other system
Genelex maintains a fully accredited, high-complexity DNA testing laboratory:
- College of American Pathologists (CAP) accreditation; 100% pass rate on CAP efficiency tests
- Clinical Laboratory Improvement Amendments (CLIA) certification; licensed to perform testing in all U.S. states
- State of New York Department of Health-accredited clinical laboratory for molecular genetic testing
- International Reference Laboratory accreditation
- Secure Laboratory Information Systems (LIS)
- Compliant with Code of Federal Regulations (CFR) 21
- Health Insurance Portability and Accountability Act (HIPAA) compliant
Genelex currently offers the following pharmacogenetic tests for research or clinical trials:
- Cytochrome P450 2D6 Genotyping
- Cytochrome P450 2C19 Genotyping
- Cytochrome P450 2C9 and VKORC1 Genotyping
- Cytochrome P450 3A4/3A5 Genotyping
- Cytochrome P450 1A2 Genotyping
- N-Acetyltransferase 2 (NAT2) Genotyping
- MTHFR
- Factor II and Factor V Leiden
- 5HTT
- DPD
- HLA-B*5701
Here is what a Quality Assurance Director had to say about his visit to Genelex:
“Everyone was very helpful, knowledgeable, and open with all of my requests. The facility is neat and orderly and designed to prevent cross-contamination of samples (e.g., segregation during various sample preparation steps for PCR amplification). The validation of the new technology was well planned and executed. All of the requirements that I like to see were performed:
- On-site training of all personnel by the Tag-it Kit manufacturer
- Parallel testing with an independent laboratory
- Testing of samples that challenge the system (Corriel Samples)
- Testing of normals (in-house blood draws)
- Duplicate testing of samples for correlation
- Development of positive controls for future testing (select Corriel Samples)
- Establishment of Proficiency Testing
All study and validation data correlated nicely and demonstrated an accurate, robust assay with a well-defined method of data interpretation.”
For more information or to request a quote, please contact Genelex at info@genelex.jp